| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/07/2008 | US20080031885 Use of Goat Serum for Veterinary Treatment |
| 02/07/2008 | US20080031881 Medicament for treating cancer |
| 02/07/2008 | US20080031873 Humanized monoclonal antibody 31.1 as an anticancer agent |
| 02/07/2008 | US20080031863 Method of Preparation and Use of Fibrinolytic Enzymes in the Treatment of Disease |
| 02/07/2008 | US20080031851 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders |
| 02/07/2008 | US20080031849 Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors |
| 02/07/2008 | US20080031824 Swellable particles for drug delivery |
| 02/07/2008 | US20080031823 Agents for therapy efficacy monitoring and deep tissue imaging |
| 02/07/2008 | US20080031817 Inhibition Of Superoxide Dismutase By Tetrathiomolybdate: Identification Of New Anti-Angiogenic And Antitumor Agents |
| 02/07/2008 | US20080031812 Redox-stable, non-phosphorylated cyclic peptide inhibitors of sh2 domain binding to target protein, conjugates, thereof, compositions and methods of synthesis and use |
| 02/07/2008 | DE102006036307A1 Medicament, useful to treat or prevent malignantly transformed cells, e.g. adeno-carcinoma, prostate carcinoma and breast carcinoma, comprises a mixture of quercetin and myrecetin and/or anisomycin and rapamycin as kinase inhibitors |
| 02/07/2008 | CA2659971A1 Fused heterocyclic derivative and use thereof |
| 02/07/2008 | CA2659861A1 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologicdisorders |
| 02/07/2008 | CA2659835A1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof |
| 02/07/2008 | CA2659697A1 Method of proliferating lak cell |
| 02/07/2008 | CA2659542A1 Methods and compositions for inhibiting angiogenesis |
| 02/07/2008 | CA2659537A1 Methods and compositions for promoting activity of anti-cancer therapies |
| 02/07/2008 | CA2658911A1 Pyrimidine compounds for combating pathogenic fungi and cancer |
| 02/07/2008 | CA2658525A1 Smac peptidomimetics useful as iap inhibitors |
| 02/07/2008 | CA2658504A1 Cancerous disease modifying antibodies |
| 02/07/2008 | CA2658340A1 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 02/07/2008 | CA2656887A1 Antitumor combinations containing taxane derivatives |
| 02/06/2008 | EP1884774A1 A method for the in vitro screening of anti-cancer compounds that inhibits SK3 activity, and said anti-cancer compounds |
| 02/06/2008 | EP1884524A2 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 02/06/2008 | EP1884523A1 Biomarkers for polo-like kinase 1 activity |
| 02/06/2008 | EP1884522A1 Antibody binding to a polo-like kinase 1 phosphorylation site of the human cohesin Wapl |
| 02/06/2008 | EP1884240A1 Pharmaceutical for prevention or treatment of bone metabolic disease |
| 02/06/2008 | EP1884239A1 Annellated pyrrole compounds for cancer management |
| 02/06/2008 | EP1883647A1 Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating b cell neoplasm |
| 02/06/2008 | EP1883638A1 Pyrrolo [2,3-d] imidazoles for the treatment of hyperproliferative disorders |
| 02/06/2008 | EP1883631A1 Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof |
| 02/06/2008 | EP1883627A1 Bir domain binding compounds |
| 02/06/2008 | EP1883453A1 A pharmaceutical composition useful for the treatment of hepatocellular carcinoma |
| 02/06/2008 | EP1883452A2 Pharmaceutical composition containing an anti parasitic agent and an active ingredient selected from carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone |
| 02/06/2008 | EP1883411A1 An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating b cell neoplasm |
| 02/06/2008 | EP1883410A2 Antibody or antibody fragment coupled with an immunogenic agent |
| 02/06/2008 | EP1309596B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/06/2008 | CN101120006A Proteasome inhibitors and methods of using the same |
| 02/06/2008 | CN101119996A Chemical compouns |
| 02/06/2008 | CN101119988A Chemical compouns |
| 02/06/2008 | CN101119987A Novel compounds |
| 02/06/2008 | CN101119978A HSP90-inhibiting triazole derivatives |
| 02/06/2008 | CN101119971A Cyclohepta[b]pyridine-3-carbonylguanidine derivative and pharmaceutical product containing same |
| 02/06/2008 | CN101119743A Immunopotentiating agent |
| 02/06/2008 | CN101119708A Bendamustine pharmaceutical compositions |
| 02/06/2008 | CN101117637A Strict hypoxia targeting carrier and uses thereof |
| 02/06/2008 | CN101117635A Fusion expression of PTD,HIF ODD and tumour inhibitory gene and uses thereof |
| 02/06/2008 | CN101117354A Esterified pine pollen polysaccharide and preparation method and use thereof |
| 02/06/2008 | CN101117349A A macrocyclic oxidation substituted pentacyclic triterpanoids derivative and preparation method and use thereof |
| 02/06/2008 | CN101117348A A and C macrocyclic oxidation substituted pentacyclic triterpanoids and preparation method and use thereof |
| 02/06/2008 | CN101117340A Ruthenium-anthraquinone conjugates, preparation method thereof and application for optical power therapeutic photosensitizer |
| 02/06/2008 | CN101116748A Adriablastina antineoplastic medicine and gland correlated virus composite preparations and uses thereof |
| 02/06/2008 | CN101116747A Cytosine arabinoside and gland correlated virus composite preparations and uses thereof |
| 02/06/2008 | CN101116745A Human papilloma virus sample particle vaccines |
| 02/06/2008 | CN101116742A Non-aqueous polar aprotic peptide formulations comprising lhrh-related compounds |
| 02/06/2008 | CN101116713A Cactus aloe anticancer capsule and method for preparing the same |
| 02/06/2008 | CN101116699A Medicine for treating tumor |
| 02/06/2008 | CN101116693A Chinese traditional medicine for treating mammary cancer |
| 02/06/2008 | CN101116669A 20(R)-ginsenoside composition and uses thereof |
| 02/06/2008 | CN101116668A Lipides moleculaires heterogenes cytotropes (lmhc), procede de preparation, et methodes de traitement de patients proteurs de cancers multiples |
| 02/06/2008 | CN101116664A Application of compound 1-( 4-chloroaniline )-4-( 4-picoline )-2, 3-naphthyridine |
| 02/06/2008 | CN100366742C IL-2 selective agonists and antagonists |
| 02/06/2008 | CN100366611C Substitutional ramification of tetrahydro-isoquinoline, as well as its preparing method and its medication compound containing them |
| 02/06/2008 | CN100366289C Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| 02/06/2008 | CN100366286C Saposin C-DOPS: a novel anti-tumor agent |
| 02/06/2008 | CN100366284C Chinese patent medicine for treaing external malignant tumor and pyogenic infections |
| 02/06/2008 | CN100366262C A medicine for treating dermatosis, venereal diseases, cancer and AIDS and preparation method thereof |
| 02/06/2008 | CN100366255C Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents |
| 02/06/2008 | CN100366253C 1,2,4-benzotriazine oxides formulations |
| 02/06/2008 | CN100366249C Control releasing administration system for temozolomide |
| 02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
| 02/05/2008 | US7326788 Quinolinone derivatives as inhibitors of c-fms kinase |
| 02/05/2008 | US7326785 Preparation of 3-(thienylalkenylenesulfonylamino)-1-(4--morpholinylcarbonyl-alpha-substituted methyl)pyrrolidone derivatives: 2-(5-Chlorothien-2-yl)-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide |
| 02/05/2008 | US7326783 Genetic engineering |
| 02/05/2008 | US7326767 Immunotherapeutic methods using epitopes of WT-1 and GATA-1 |
| 02/05/2008 | US7326729 CXCR1 and CXCR2 chemokine antagonists |
| 02/05/2008 | US7326727 Furanthiazole derivatives as heparanase inhibitors |
| 02/05/2008 | US7326723 Autoimmune disease; antiinflammatory agents |
| 02/05/2008 | US7326713 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 6,7-dimethoxy-4-(4-(benzodioxol-5-ylmethylaminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole |
| 02/05/2008 | US7326712 Substituted tricyclic compounds as protein kinase inhibitors |
| 02/05/2008 | US7326711 Antiproliferative agents for humans, animals |
| 02/05/2008 | US7326699 4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives |
| 02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
| 02/05/2008 | US7326685 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 02/05/2008 | US7326529 Using cancer specific genes |
| 02/05/2008 | US7326418 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
| 02/05/2008 | US7326415 derived from epithelial cells and malignant lymphoma; also for irritable bowel syndrome, viral and other infections; genetic engineering; kits |
| 02/05/2008 | US7326414 Monoclonal antibody that specifically binds macrophage colony stimulating factor; rheumatoid arthritis |
| 02/05/2008 | US7326411 Use of amino-terminally truncated RANTES to inhibit HIV viral replication |
| 02/05/2008 | CA2417635C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/05/2008 | CA2413515C Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them |
| 02/05/2008 | CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 02/05/2008 | CA2349227C Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 02/05/2008 | CA2315685C Molecular dispersion composition with enhanced bioavailability |
| 02/05/2008 | CA2199893C 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives |
| 02/05/2008 | CA2191077C Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties |
| 02/05/2008 | CA2187161C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase ii (icerel-ii) |
| 02/05/2008 | CA2136339C Derivatives of dolastatin |
| 01/31/2008 | WO2008014291A2 Compounds and compositions as hedgehog signaling pathway modulators |